Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience said after the close of the market on Monday that its preliminary fiscal first quarter revenues are expected to be down about 2 percent year over year.

For fiscal Q1 2019, the company said that revenues are anticipated to be in the range of $51 million to $51.5 million compared to $52.3 million a year ago. The analysts' average estimate is $53.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.